NEUROVENTI

City:

Seoul

Country:

South Korea

Published Applications:

Last publication date:

2023-02-23

Patent Grants:

Last grant date:

2025-08-26

Top Inventors for applications by NEUROVENTI

These are the the leading inventors for applications assigned to NEUROVENTI:

Taejin Ahn 2 Seoul, South Korea
Sejin Jeon 2 Seoul, South Korea
Sohyun JOO 2 Seoul, South Korea
Chanyoung SHIN 2 Seoul, South Korea

Chanyoung SHIN 1 Sittard, South Korea
Chan Young Shin 1 Seoul, South Korea

Recent patent applications by NEUROVENTI

NEUROVENTI based in Seoul, KR has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2023-02-23 ✅ Patent 12,396,983 granted on 2025-08-26

US20230055339A1

Human necessities

COMPOSITION COMPRISING RILMENIDINE COMPOUND AS ACTIVE INGREDIENT FOR TREATMENT OF FRAGILE X SYNDROME OR RELATED DEVELOPMENTAL DISABILITY

#2 | 2023-01-26

US20230024384A1

Human necessities

COMPOSITION COMPRISING LISURIDE COMPOUND FOR TREATING FRAGILE X SYNDROME OR RELATED DEVELOPMENTAL DISORDERS

#3 | 2019-07-04 ✅ Patent 10,787,426 granted on 2020-09-29

US20190202796A1

Chemistry; metallurgy

Method of treating autism spectrum disorders using piperazine-1-carboxamidine or pharmaceutically acceptable salt thereof

Also check out NEUROVENTI's (Seoul, South Korea) applicant profile with 2 patent applications submitted.

AssigneeID:

333226 ⎘